104 related articles for article (PubMed ID: 10443957)
21. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
Carmignoto F; Schivo P; Plebani M; Pengo V; Piccini P; Ceriotti G
Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980
[TBL] [Abstract][Full Text] [Related]
22. [Role of newly developed technology in blood coagulation disorders].
Matsuo T
Rinsho Byori; 2002 May; 50(5):506-12. PubMed ID: 12078050
[TBL] [Abstract][Full Text] [Related]
23. Antithrombin: its physiological importance and role in DIC.
Mammen EF
Semin Thromb Hemost; 1998; 24(1):19-25. PubMed ID: 9515776
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
25. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
[TBL] [Abstract][Full Text] [Related]
26. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
27. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
[TBL] [Abstract][Full Text] [Related]
28. [Antithrombin III. Physiologic, physiopathologic and laboratory aspects].
de Sousa JC; Ferreira R; Carriço F; Nunes V; Geraldes MJ; Parreira F; Ribeiro C
Rev Port Cardiol; 1991 Sep; 10(9):693-9. PubMed ID: 1747261
[TBL] [Abstract][Full Text] [Related]
29. [Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency].
Gerhards H
Tierarztl Prax; 1987; 15(1):47-55. PubMed ID: 3590168
[TBL] [Abstract][Full Text] [Related]
30. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
31. [Pathogenetic mechanism and clinical relevance of acquired anti-thrombin III deficiency in internal medicine (author's transl)].
Thaler E
Wien Klin Wochenschr; 1981 Oct; 93(18):563-72. PubMed ID: 7029926
[TBL] [Abstract][Full Text] [Related]
32. Laboratory determination of heparin cofactor II.
Ezenagu LC; Brandt JT
Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
[TBL] [Abstract][Full Text] [Related]
33. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
Bergmann H; Blauhut B; Necek S; Kramar H; Vinazzer H
Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
[TBL] [Abstract][Full Text] [Related]
34. Inherited antithrombin deficiency: a review.
Patnaik MM; Moll S
Haemophilia; 2008 Nov; 14(6):1229-39. PubMed ID: 19141163
[TBL] [Abstract][Full Text] [Related]
35. [A case of congenital antithrombin II deficiency with pulmonary infarction].
Terashima T; Suzuki Y; Kawai A; Yamaguchi K; Yokoyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Feb; 29(2):276-81. PubMed ID: 2033902
[TBL] [Abstract][Full Text] [Related]
36. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
37. [Disseminated intravascular coagulation. II. Therapeutic problems].
Boccaccio P; Ghio R; Ratti M; Casciaro S; Rattenni S; Sergnese G
Minerva Med; 1982 Feb; 73(7):309-20. PubMed ID: 6173819
[TBL] [Abstract][Full Text] [Related]
38. Hypercoagulability and thrombosis.
Bick RL; Ucar K
Hematol Oncol Clin North Am; 1992 Dec; 6(6):1421-31. PubMed ID: 1452521
[TBL] [Abstract][Full Text] [Related]
39. Management of acquired coagulation disorders in emergency and intensive-care medicine.
Staudinger T; Locker GJ; Frass M
Semin Thromb Hemost; 1996; 22(1):93-104. PubMed ID: 8711494
[TBL] [Abstract][Full Text] [Related]
40. Mesenteric venous thrombosis due to antithrombin III deficiency.
Maung R; Kelly JK; Schneider MP; Poon MC
Arch Pathol Lab Med; 1988 Jan; 112(1):37-9. PubMed ID: 3337617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
